Brought together by conjugation: CMC Biologics A/S and IDT Biologika form ADC pact

By Gareth Macdonald contact

- Last updated on GMT


Related tags: Tuberculosis, Clinical trial

CMC Biologics A/S and IDT Biologika GmbH have teamed up to offer drugmakers an antibody drug conjugate manufacturing service.

The collaboration - financial terms of which were not disclosed – will see CMC provide process development and bulk antibody manufacturing services, while IDT will focus on conjugating the drug warheads to the antibodies. IDT will also handle fill finish and packaging.

The aim is to provide drug industry customers with a faster means of making ADC for clinical trials and commercial launch.

IDT CEO Ralf Pfirmann said: "The collaboration with CMC Biologics is an important step to provide full ADC manufacturing services to meet the needs of ADC development and production in this rapidly growing field​."

This was echoed by CMC CEO, Gustavo Mahler, who said: "We are delighted to be working with IDT Biologika, one of the fastest growing and innovative CMOs in Germany and now in North America.”

The deal comes a few months after IDT has opened its first facility in the US. The vaccine manufacturing site in Rockville, Maryland provides process development, cell banking, cGMP manufacturing, purification and formulation, and fill/finish services.

IDT bought the facility last June from Aeras, which is a non-profit research company focused on tuberculosis vaccine development.

Related news

Show more

Related products

show more

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

The Reagents Behind Much of Molecular Biology

The Reagents Behind Much of Molecular Biology

Thermo Fisher Scientific | 25-Jul-2022 | Case Study

The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Related suppliers

Follow us


View more